Form 8-K - Current report:
SEC Accession No. 0001564590-20-037720
Filing Date
2020-08-06
Accepted
2020-08-06 16:06:29
Documents
14
Period of Report
2020-08-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fgen-8k_20200805.htm   iXBRL 8-K 39147
2 EX-99.1 fgen-ex991_15.htm EX-99.1 18223
3 GRAPHIC g5xvr2qrnvih000001.jpg GRAPHIC 4421
  Complete submission text file 0001564590-20-037720.txt   195245

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fgen-20200805.xsd EX-101.SCH 5776
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20200805_lab.xml EX-101.LAB 18736
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20200805_pre.xml EX-101.PRE 11177
7 EXTRACTED XBRL INSTANCE DOCUMENT fgen-8k_20200805_htm.xml XML 3406
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 201081581
SIC: 2834 Pharmaceutical Preparations